SCHEMBL284445

SCHEMBL284445

C[CH]CC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23467140 0.96
Malonaldehyde SCHEMBL6877197 0.78
SCHEMBL42541 0.71
Malonaldehyde SCHEMBL10949336 0.71 ALDH1A1 (0.42)
Malonaldehyde SCHEMBL16287 0.71
Malonaldehyde SCHEMBL4259871 0.70
SCHEMBL6297993 0.69
SCHEMBL258859 0.69
SCHEMBL490428 0.69
Malonaldehyde SCHEMBL8182493 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 328 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2958928-A1 ESTRA-1,3,5(10),16-TETRAENE-3-CARBOXAMIDES FOR INHIBITION OF 17.BETA.-HYDROXYSTEROID DEHYDROGENASE (AKR1 C3) Bayer Pharma Aktiengesellschaft (DE) 2015-12-30 EP claimed
EP-2776407-A1 MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2014-09-17 EP claimed
WO-2014128108-A1 ESTRA-1,3,5(10),16-TETRAENE-3-CARBOXAMIDES FOR INHIBITION OF 17.BETA.-HYDROXYSTEROID DEHYDROGENASE (AKR1 C3) BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-08-28 WO claimed
EP-2678334-A1 ANTI-VIRAL COMPOUNDS Abbvie Inc. (US) 2014-01-01 EP claimed
WO-2013070657-A1 MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2013-05-16 WO claimed
CN-103080108-A Pyridyl-amine fused azadecalin modulators CORCEPT THERAPEUTICS INC 2013-05-01 CN claimed
CN-102918027-A Modulators of the gpr119 receptor and the treatment of disorders related thereto ARENA PHARM INC 2013-02-06 CN claimed
CN-102725290-A Fused heterocyclic compounds as ion channel modulators GILEAD PALO ALTO INC 2012-10-10 CN claimed
WO-2012116257-A1 ANTI-VIRAL COMPOUNDS ABBVIE INC. (US) 2012-08-30 WO claimed
CN-1211385-C Bicyclic imidazo-5-yl-amine derivs. GRUENENTHAL GMBH (DE) 2005-07-20 CN claimed
CN-118354759-A Compositions comprising 2' -deoxycytidine analogs and their use for treating sickle cell disease, thalassemia and cancer 阿基拉比奥有限公司 2024-07-16 CN disclosed
US-20240216372-A1 THERAPEUTICS FOR KELOIDS AND OTHER FIBROTIC DISORDERS NATIONAL INSTITUTES OF HEALTH 2024-07-04 US disclosed
US-20240207359-A1 INHIBITION OF BETA-ARRESTIN OLIGOMERIZATION IN TAUOPATHY UNIVERSITY OF SOUTH FLORIDA 2024-06-27 US disclosed
EP-4387626-A1 ALLOPREGNANOLONE ANALOGUES FOR HIV VIREMIA AND NEUROTOXICITY PROTECTION University of Mississippi (US) 2024-06-26 EP disclosed
EP-3793562-B1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE OHIO STATE INNOVATION FOUNDATION (US) 2024-06-19 EP disclosed
EP-0242767-A2 N-dihydroindolyl ethyl-sulfon amides BAYER AG (DE) 1987-10-28 EP disclosed
US-4528352-A RTV silicon compositions and processes GENERAL ELECTRIC COMPANY (US) 1985-07-09 US disclosed
US-4288374-A MULTISTAGE FROM PROPYLENE AND FORMALDEHYDE USING ALCOHOL STABILIZED SILICA SAND E. I. DU PONT DE NEMOURS AND COMPANY (US) 1981-09-08 US disclosed
US-4261901-A Synthesis of tetrahydrofuran E. I. DU PONT DE NEMOURS AND COMPANY (US) 1981-04-14 US disclosed
US-4249938-A HERBICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-02-10 US disclosed